Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.

ABSTRACT:

Importance

Use of medications for attention-deficit/hyperactivity disorder (ADHD) during pregnancy is increasing in the US. Whether exposure to these medications in utero impacts the risk of neurodevelopmental disorders in children is uncertain.

Objective

To evaluate the association of childhood neurodevelopmental disorders with in utero exposure to stimulant medications for ADHD.

Design, setting, and participants

This cohort study included health care utilization data from publicly insured (Medicaid data from 2000 to 2018) and commercially insured (MarketScan Commercial Claims Database data from 2003 to 2020) pregnant individuals aged 12 to 55 years in the US with enrollment from 3 months prior to pregnancy through 1 month after delivery, linked to children. Children

SUBMITTER: Suarez EA 

PROVIDER: S-EPMC10809143 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature